News | May 12, 2025
Kwality Pharmaceuticals concludes regulatory audit for Zimbabwe
This marks yet another milestone in our series of successful audits over the past year
This marks yet another milestone in our series of successful audits over the past year
This approval is a significant achievement in expanding the availability of this critical therapeutic,
Kwality Pharma already has registration of 20 molecules from the units and 20 are under registration
Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies
The company has reported total income of Rs. 70.59 crores during the period ended June 30, 2022.
Subscribe To Our Newsletter & Stay Updated
